FV

Flagship Ventures Fund V General Partner LLC

Codiak BioSciences, Inc.Sana Biotechnology, Inc.Sigilon Therapeutics, Inc.

Cumul. flow

0

Total declarations

0

Companies

—

▲ Purchases (1 ops.)

€3m

▼ Sales (2 ops.)

Insider track record

Other

Disclosed buys

1

Disclosed sells

2

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Discover the full record of transactions filed by Flagship Ventures Fund V General Partner LLC. Director active across 3 companies, notably Codiak BioSciences, Inc.. Cumulatively, 5 disclosures have been logged. Breakdown: 1 buy · 2 sells. Total volume traded: €3m. Activity tracked since 24 May 2023. The latest transaction was filed on 11 August 2023 (U). Regulator: SEC (Form 4). The full history is accessible without signup.

Declarations5 total

●

Flagship Ventures Fund V General Partner LLC

Executives11 Aug 2023Sigilon Therapeutics, Inc.

$10M10SEC ↗

683,760 shares@ US$14.9285.7% of flowCommon StockSEC:0000899243-23-018154:0

●

Flagship Ventures Fund V General Partner LLC

10% OwnerExecutives11 Aug 2023Sigilon Therapeutics, Inc.

$2M3SEC ↗

113,960 shares@ US$14.9214.3% of flowCommon StockSEC:0000899243-23-018154:1

▼